Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

@article{Tallman2000EffectOP,
  title={Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.},
  author={Martin S. Tallman and Philip A Rowlings and Giuseppe Milone and Mei Jie Zhang and Waleska S. P{\'e}rez and Daniel H Weisdorf and Armand Keating and Robert Peter Gale and Robert B. Geller and Mary J. Laughlin and Hillard M Lazarus and Selina M. Luger and Philip L McCarthy and Jacob M. Rowe and Ruben A Saez and Marcus R Vowels and Mary M. Horowitz},
  journal={Blood},
  year={2000},
  volume={96 4},
  pages={1254-8}
}
Allogeneic bone marrow transplantation is an effective postremission strategy for patients with acute myelogenous leukemia (AML) in first complete remission (CR). The value of administering consolidation chemotherapy before human leukocyte antigen (HLA)-identical sibling transplantation is not established. Outcomes of patients with AML in first CR receiving no consolidation therapy, standard-dose cytarabine consolidation therapy, and high-dose cytarabine consolidation therapy before HLA… CONTINUE READING
33 Citations
24 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Induction and postremission therapy in acute myeloid leukemia: experiences of the Eastern Cooperative Oncology Group (ECOG)

  • JM Rowe, ML Young, PA Cassileth, JM Bennett, MS Tallman, PH. Wiernik
  • 1988
Highly Influential
5 Excerpts

Non-parametric estimation from incomplete observations

  • EL Kaplan, P. Meier
  • J Am Stat Assoc.1958;53:457-481,
  • 1958
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…